Understand how telomeres influence your patients’ health!
Having trouble viewing this email? Click to view this in your browser.
 
Toll-Free: 888.360.8886
 

4th Annual TA-65® Advanced Training Program


When: Wednesday, Nov 1st, 2017

(prior to AMMG Conference 2017)


Time: 4:00 - 8:00 pm (Dinner Included)


Where: JW Marriott Starr Pass Resort & Spa, Tucson, AZ

(San Ignacio Room)


REGISTER NOW!
 
 
  Are you interested in learning about the latest scientific research surrounding telomerase activation in respect to your patient’s health?

It is scientifically proven that telomeres shorten with age, due to cellular replication, lifestyle and environmental factors. Join us for a cutting-edge training workshop which will bring together current practitioners who will review the current science as well as discuss the importance of understanding telomerase activation and successful patient outcomes with TA-65®.
 
 
 
 
Featured Speaker
 
 
  Joseph Raffaele, M.D. – received his B.A. in philosophy from Princeton University and his MD from Hahnemann University Medical School in 1989. Dr. Raffaele trained at The New York Hospital/Cornell University Medical Center and was formerly a clinical assistant professor of medicine at Dartmouth Medical School while in practice at the Hitchcock Clinic. Dr. Raffaele is a member of the Endocrine Society, is board certified in internal medicine, and is a diplomat of the American Board of Anti-Aging Medicine. In 1997, he co-founded PhysioAge Medical Group where he exclusively practiced age management medicine with a focus on personalized hormone optimization and physiological age assessment. In 2007, his co-founded PhysioAge Systems, a web-based biomarker data collection and reporting system now used by age management practices around the world to assess, monitor, and communicate to patients the effectiveness of their treatments. Since 2009, he has been involved in clinical telomere biology research and published 3 studies of the effect of oral telomerase activators on normal aging adults. He has lectured nationally and internationally on the clinical application of telomere biology. In 2015 he founded Raffaele Medical Group and blogs regularly about telomere biology, hormone optimization, and biomarkers of aging on DrRaffaele.com and PhysioAgeSystems.com  
 
 
 
  Learn More About Telomere Biology Today!
 
 
TA-65® is Supported by
Published Clinical Data
 
First Randomized, Double-Blind, Placebo-Controlled
Study to Show Telomere Lengthening in Humans
 
TA-65® Group
Increase vs placebo group in median telomere length over 12 months taking one 250 unit capsule capsule a day!
Median telomere length
   533 ± 180 bp
20th percentile telomere length
   270 ± 90 bp
 
Placebo Group
Decrease in median telomere length over 12 months
Median telomere length
   290 ± 100 bp
20th percentile telomere length
   170 ± 50 bp
 
You can have confidence your patients are taking a safe and effective supplement that supports healthy living at the cellular level.
 
 
 
TA-65® Provider revenue Potential
 
TA-65® providers recommend the supplement to patients and make it conveniently available in their office. The chart below shows the potential annual ancillary revenue a physician can make by becoming a provider.
 
bar graph
 
* at the starting dose
 
REGISTER NOW!
 
 
    420 Lexington Ave., Suite 2900 New York, NY 10170 USA
Follow Us On: